Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 15 | 2020 | 179 | 3.920 |
Why?
|
| Kidney Transplantation | 11 | 2020 | 517 | 2.560 |
Why?
|
| Tissue Donors | 8 | 2017 | 198 | 2.260 |
Why?
|
| Kidney Failure, Chronic | 5 | 2017 | 543 | 1.000 |
Why?
|
| Tissue and Organ Procurement | 5 | 2017 | 93 | 0.900 |
Why?
|
| Donor Selection | 3 | 2020 | 33 | 0.900 |
Why?
|
| Graft Survival | 5 | 2019 | 313 | 0.820 |
Why?
|
| Postoperative Complications | 6 | 2020 | 780 | 0.790 |
Why?
|
| Renal Insufficiency | 2 | 2020 | 58 | 0.770 |
Why?
|
| Liver Failure | 1 | 2020 | 20 | 0.700 |
Why?
|
| Waiting Lists | 3 | 2017 | 34 | 0.640 |
Why?
|
| Brain Death | 3 | 2012 | 26 | 0.600 |
Why?
|
| Poverty | 1 | 2018 | 111 | 0.570 |
Why?
|
| Bile Duct Diseases | 3 | 2011 | 10 | 0.530 |
Why?
|
| Registries | 3 | 2017 | 298 | 0.500 |
Why?
|
| Death | 2 | 2012 | 49 | 0.490 |
Why?
|
| Liver Diseases | 2 | 2013 | 70 | 0.480 |
Why?
|
| Living Donors | 4 | 2020 | 64 | 0.470 |
Why?
|
| Comparative Effectiveness Research | 2 | 2014 | 25 | 0.460 |
Why?
|
| Retrospective Studies | 10 | 2020 | 3509 | 0.460 |
Why?
|
| Middle Aged | 13 | 2020 | 11817 | 0.390 |
Why?
|
| Models, Statistical | 1 | 2012 | 175 | 0.380 |
Why?
|
| Renal Dialysis | 4 | 2017 | 282 | 0.370 |
Why?
|
| Humans | 24 | 2020 | 32005 | 0.360 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2011 | 62 | 0.360 |
Why?
|
| United States | 7 | 2017 | 3939 | 0.350 |
Why?
|
| Heart Arrest | 1 | 2010 | 38 | 0.350 |
Why?
|
| Risk Factors | 7 | 2017 | 3876 | 0.330 |
Why?
|
| Health Care Costs | 1 | 2010 | 118 | 0.320 |
Why?
|
| Adult | 12 | 2020 | 9345 | 0.320 |
Why?
|
| Male | 15 | 2020 | 19165 | 0.310 |
Why?
|
| Quality of Life | 2 | 2016 | 946 | 0.310 |
Why?
|
| Female | 13 | 2020 | 19959 | 0.270 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 753 | 0.270 |
Why?
|
| Time Factors | 4 | 2020 | 2149 | 0.260 |
Why?
|
| Treatment Outcome | 7 | 2017 | 3306 | 0.230 |
Why?
|
| Aged | 6 | 2020 | 10301 | 0.220 |
Why?
|
| Cost-Benefit Analysis | 2 | 2013 | 185 | 0.200 |
Why?
|
| Risk Assessment | 4 | 2017 | 1426 | 0.200 |
Why?
|
| Transplantation, Homologous | 2 | 2020 | 151 | 0.180 |
Why?
|
| Ischemia | 2 | 2011 | 98 | 0.170 |
Why?
|
| Genetic Testing | 1 | 2020 | 96 | 0.170 |
Why?
|
| Age Factors | 3 | 2019 | 1188 | 0.170 |
Why?
|
| Survival Analysis | 4 | 2019 | 483 | 0.170 |
Why?
|
| Markov Chains | 3 | 2015 | 29 | 0.160 |
Why?
|
| Survival Rate | 1 | 2020 | 877 | 0.150 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2017 | 32 | 0.140 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 59 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2015 | 220 | 0.140 |
Why?
|
| Nephrology | 1 | 2017 | 33 | 0.140 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 107 | 0.140 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 297 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 291 | 0.140 |
Why?
|
| Continental Population Groups | 1 | 2018 | 237 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 308 | 0.130 |
Why?
|
| Tissue and Organ Harvesting | 2 | 2020 | 35 | 0.130 |
Why?
|
| Minority Groups | 1 | 2016 | 78 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 167 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 684 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2265 | 0.120 |
Why?
|
| Policy Making | 1 | 2015 | 20 | 0.120 |
Why?
|
| Ethnic Groups | 1 | 2018 | 476 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2016 | 177 | 0.120 |
Why?
|
| Medicare | 1 | 2016 | 206 | 0.120 |
Why?
|
| Prognosis | 2 | 2017 | 1497 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2015 | 137 | 0.110 |
Why?
|
| Health Resources | 2 | 2010 | 32 | 0.110 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2013 | 31 | 0.110 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 401 | 0.110 |
Why?
|
| Young Adult | 2 | 2019 | 2636 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 241 | 0.100 |
Why?
|
| Decision Trees | 1 | 2012 | 31 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 475 | 0.100 |
Why?
|
| Informed Consent | 1 | 2011 | 34 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2014 | 249 | 0.100 |
Why?
|
| Primary Graft Dysfunction | 1 | 2011 | 1 | 0.100 |
Why?
|
| Biliary Tract Diseases | 1 | 2011 | 12 | 0.090 |
Why?
|
| Renal Veins | 1 | 2010 | 7 | 0.090 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2010 | 12 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2011 | 60 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 1 | 2011 | 77 | 0.090 |
Why?
|
| Patient Selection | 1 | 2012 | 276 | 0.090 |
Why?
|
| Age Distribution | 1 | 2011 | 206 | 0.090 |
Why?
|
| Heart Failure | 1 | 2016 | 639 | 0.090 |
Why?
|
| Reoperation | 1 | 2011 | 226 | 0.090 |
Why?
|
| Cause of Death | 1 | 2011 | 236 | 0.090 |
Why?
|
| Hospital Costs | 1 | 2010 | 38 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2011 | 238 | 0.080 |
Why?
|
| Hepatectomy | 1 | 2009 | 56 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 155 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2009 | 73 | 0.080 |
Why?
|
| Psychometrics | 1 | 2009 | 137 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2009 | 172 | 0.070 |
Why?
|
| Liver | 1 | 2010 | 484 | 0.070 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2006 | 1 | 0.070 |
Why?
|
| Biliary Atresia | 1 | 2006 | 3 | 0.070 |
Why?
|
| Ileus | 1 | 2005 | 4 | 0.070 |
Why?
|
| Pneumothorax | 1 | 2005 | 8 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2006 | 31 | 0.070 |
Why?
|
| Intestinal Diseases | 1 | 2005 | 16 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2005 | 23 | 0.060 |
Why?
|
| Peptides | 1 | 2006 | 120 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 122 | 0.060 |
Why?
|
| Infant | 3 | 2019 | 1061 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2019 | 1269 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2020 | 123 | 0.040 |
Why?
|
| African Continental Ancestry Group | 1 | 2020 | 363 | 0.040 |
Why?
|
| Child | 2 | 2019 | 2438 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 407 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 185 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 835 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2017 | 129 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2016 | 153 | 0.030 |
Why?
|
| Adolescent | 2 | 2019 | 3539 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 566 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 781 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2006 | 671 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 762 | 0.030 |
Why?
|
| Empirical Research | 1 | 2011 | 9 | 0.030 |
Why?
|
| Liver Circulation | 1 | 2010 | 7 | 0.020 |
Why?
|
| Mesenteric Veins | 1 | 2010 | 9 | 0.020 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2010 | 6 | 0.020 |
Why?
|
| Iliac Vein | 1 | 2010 | 8 | 0.020 |
Why?
|
| Portal Vein | 1 | 2010 | 27 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 86 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2010 | 26 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2009 | 24 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 271 | 0.020 |
Why?
|
| Decision Making | 1 | 2011 | 195 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2009 | 32 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 11 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2009 | 923 | 0.020 |
Why?
|
| Meconium | 1 | 2005 | 2 | 0.020 |
Why?
|
| Intussusception | 1 | 2005 | 2 | 0.020 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2005 | 13 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 170 | 0.020 |
Why?
|
| Abdomen | 1 | 2005 | 43 | 0.020 |
Why?
|
| Proteomics | 1 | 2006 | 94 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2006 | 231 | 0.010 |
Why?
|